Edwards Lifesciences Corporation provided earnings guidance for the third quarter of 2022 and second half of 2022. For the third quarter, the company projects total sales to be between $1.30 and $1.37 billion.

For the year, the company expects full year 2022 sales of $5.35 to $5.55 billion.